Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PON1 | P27169 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899047 | 0.90 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Fluoride Ion SCHEMBL1892964 | 0.89 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Hydrochloric Acid SCHEMBL6115333 | 0.89 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL16731564 | 0.76 | APAF1 (0.54) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL899258 | 0.76 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL17706400 | 0.74 | SMN1; SMN2 (0.43) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Bromide SCHEMBL6116136 | 0.74 | SMN1; SMN2 (0.56) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL425211 | 0.74 | — | — | |
| SCHEMBL21821199 | 0.74 | APAF1 (0.60) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL3114494 | 0.74 | APAF1 (0.60) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230327207-A1 | Storage Battery, Battery Control Unit, and Electronic Device | SEMICONDUCTOR ENERGY LAB (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230231199-A1 | SECONDARY BATTERY AND VEHICLE INCLUDING SECONDARY BATTERY | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20200280101-A1 | STORAGE BATTERY, BATTERY CONTROL UNIT, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2020-09-03 | — | — | US | disclosed |
| US-10658701-B2 | Storage battery, battery control unit, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20170237127-A1 | ELECTRODE, MANUFACTURING METHOD THEREOF, NEGATIVE ELECTRODE, MANUFACTURING METHOD THEREOF, POWER STORAGE DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170222265-A1 | STORAGE BATTERY, BATTERY CONTROL UNIT, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20160118637-A1 | POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | VDAC3, VDAC2, SCO2 | SMN1; SMN2 449/4885MEN1 2332/4885APAF1 3371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.